New grad roles at Autolus Therapeutics plc
Autolus Therapeutics is an early commercial-stage biopharmaceutical company that develops, manufactures, and delivers programmed T-cell therapies for cancer and autoimmune diseases. Its lead product, AUCATZYL, is approved for adults with relapsed or refractory B-cell acute lymphoblastic leukemia.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 501–1,000 employees
- Stage
- Public
- Open roles
- 11
No current roles
Clear a filter to see every role.
Get new Autolus Therapeutics plc new grad roles by email
Free account. Get new Autolus Therapeutics plc new grad roles by email or push the minute they post.

